AAAAAA

   
Results: 1-7 |
Results: 7
CYTOGENETIC AND MOLECULAR-BIOLOGY FOR ACUTE LEUKEMIAS AT DIAGNOSIS - A COST EFFECTIVENESS COMPARISON/
Authors: TONNAIRE G GABERT J LAFAGEPOCHITALOFF M MOZZICONACCI MJ TOIRON Y SAINTY D MARANINCHI D MOATTI JP
Citation: G. Tonnaire et al., CYTOGENETIC AND MOLECULAR-BIOLOGY FOR ACUTE LEUKEMIAS AT DIAGNOSIS - A COST EFFECTIVENESS COMPARISON/, Leukemia & lymphoma, 28(3-4), 1998, pp. 363-370
AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION
Authors: FORTANIER C FAUCHER C TONNAIRE G PROTIERE C LECOROLLIER AG BLAISE D MOATTI JP
Citation: C. Fortanier et al., AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION, European journal of cancer, 33, 1997, pp. 23-23
INSTITUTIONAL STRUCTURE, FINANCING MECHANISMS AND HETEROGENEITY IN HEALTH-CARE SUPPLY - EXPERIENCE FROM 1078 BREAST-CANCER PATIENTS IN A FRENCH REGION
Authors: TONNAIRE G PARAPONARIS A CHANUT C SAMBUC R
Citation: G. Tonnaire et al., INSTITUTIONAL STRUCTURE, FINANCING MECHANISMS AND HETEROGENEITY IN HEALTH-CARE SUPPLY - EXPERIENCE FROM 1078 BREAST-CANCER PATIENTS IN A FRENCH REGION, European journal of cancer, 33, 1997, pp. 29-29
COST EFFECTIVENESS ASSESSMENT OF CYTOGENETIC AND MOLECULAR-BIOLOGY ANALYSIS FOR ACUTE LEUKEMIAS PROGNOSIS/
Authors: TONNAIRE G GABERT J LAFAGE M SAINTY D MARANINCHI D MOATTI JP
Citation: G. Tonnaire et al., COST EFFECTIVENESS ASSESSMENT OF CYTOGENETIC AND MOLECULAR-BIOLOGY ANALYSIS FOR ACUTE LEUKEMIAS PROGNOSIS/, European journal of cancer, 33, 1997, pp. 62-62
A PILOT-STUDY TO EVALUATE THE FEASIBILITY OF USING EXPANDED MARROW-CELLS AND PROGENITORS TO SUPPORT SEQUENTIAL HIGH-DOSES OF ALKYLATING-AGENTS IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: CHABANNON C SIELLEUR I DOUVILLE J BLACHE JL FAUCHER C TONNAIRE G NOVAKOVITCH G APPEL M FISH R GRAVIS G BERTUCCI F STOPPA AM BLAISE D CHABBERT I MOATTI JP MULLER T OGIER W ARMSTRONG D MARANINCHI D VIENS P
Citation: C. Chabannon et al., A PILOT-STUDY TO EVALUATE THE FEASIBILITY OF USING EXPANDED MARROW-CELLS AND PROGENITORS TO SUPPORT SEQUENTIAL HIGH-DOSES OF ALKYLATING-AGENTS IN PATIENTS WITH ADVANCED BREAST-CANCER, Experimental hematology, 25(8), 1997, pp. 277-277
CYTOGENETIC AND MOLECULAR ANALYSIS FOR ACUTE LEUKEMIAS AT DIAGNOSIS -A COST EFFECTIVENESS STUDY/
Authors: GABERT J TONNAIRE G LAFAGEPOCHITALOFF M SAINTY D MARANINCHI D MOATTI JP
Citation: J. Gabert et al., CYTOGENETIC AND MOLECULAR ANALYSIS FOR ACUTE LEUKEMIAS AT DIAGNOSIS -A COST EFFECTIVENESS STUDY/, Blood, 88(10), 1996, pp. 292-292
COMPARISON OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION CLINICAL AND COST-EFFECTIVENESS STUDY
Authors: FAUCHER C FORTANIER C PROTIERE C TONNAIRE G CHABANNON C LECORROLLER AG CHARBONNIER A BANCILLON A BRADI N NOVAKOVITCH G MOATTI JP MARANINCHI D BLAISE D
Citation: C. Faucher et al., COMPARISON OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION CLINICAL AND COST-EFFECTIVENESS STUDY, Blood, 86(10), 1995, pp. 1528-1528
Risultati: 1-7 |